PF 04620110
Chemical Name: trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic acid
Purity: ≥98%
Biological Activity
PF 04620110 is a potent and selective DGAT-1 inhibitor (IC50 = 19 nM). Exhibits >1000-fold selectivity for DGAT-1 over DGAT-2, and no significant activity against a range of other enzymes, ion channels and receptors. Reduces plasma triglyceride levels in a rat lipid challenge model. Orally bioavailable.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
Discovery of PF-04620110, a potent, selective, and orally bioavailable inhibitor of DGAT-1.
Dow et al.
ACS Med.Chem.Lett., 2011;2:407
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for PF 04620110
The citations listed below are publications that use Tocris products. Selected citations for PF 04620110 include:
1 Citation: Showing 1 - 1
-
ABHD5 suppresses cancer cell anabolism through lipolysis-dependent activation of the AMPK/mTORC1 pathway.
Authors: Jian Et al.
J Biol Chem 2020;296:100104
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for PF 04620110
There are currently no reviews for this product. Be the first to review PF 04620110 and earn rewards!
Have you used PF 04620110?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image